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Abstract
The management algorithm surrounding necrotizing pancreatitis has altered radically in the last 15 years in response to
evolving concepts, improved understanding and the development of minimally invasive techniques, including percutaneous
necrosectomy, and laparoscopic or EUS-guided cystgastrostomy. This article discusses the emerging role of minimally
invasive techniques, key to which is an understanding of the evolving pathology of post acute, necrosis-associated fluid
collections in pancreatitis. A dynamic and multi-modal management approach is presented, the aim of intervention being
the ‘adequate and maintained control of sepsis’: the choice of technique dependent on the anatomical position, the ratio of
solid to fluid components within the collection, and in particular the degree of systemic organ dysfunction.
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Introduction
The management algorithm surrounding necrotizing
pancreatitis has altered radically in the last 15 years in
response to evolving concepts, improved understand-
ing and the development of alternative techniques.
The median inpatient stay for a patient with infected
necrosis is in excess of 2 months and no single
approach is seen as universally appropriate. A multi-
disciplinary approach has evolved, and it is now
common for several techniques to be utilized in a
single patient, as the indications and clinical condition
of the patient alter during that period.
Approximately 15% of patients with acute pancrea-
titis will have CT evidence of hypoperfusion on an
early contrast-enhanced CT scan. The necrotic pro-
cess is not limited to the pancreas and peri-pancreatic
necrosis may occur alongside relatively minor degrees
of parenchymal damage [1]. This is particularly so in
the obese patient, and an excessive body mass index
(BMI) is recognized to adversely affect outcome [2].
Initial extension of the pancreatic and peri-pancreatic
inflammation leads to interstitial oedema, and a
variable degree of devitalized tissue. The oedema
within this initially essentially solid inflammatory
mass subsequently coalesces into acute fluid collec-
tions, and over a period of weeks, the demarcation
between viable and necrotic tissue becomes estab-
lished, the collection becomes lined with granulation
tissue.
The traditional approach to the management of a
patient with necrotizing pancreatitis centred on the
early diagnosis and particularly an aggressive ap-
proach to infection within that necrosis, as this was
assumed to be key to clinical resolution. There is
undoubtedly a relationship between the extent of
necrosis and outcome, and the presence of infection
and outcome; survival is more intimately related to
the co-existence of organ failure [3,4]. Indeed sig-
nificant necrosis and occasionally infection within that
necrosis can occur without significant systemic upset.
In managing the patients with severe acute pan-
creatitis, there are two distinct phases where inter-
vention is considered: Early (within 12 weeks of
admission), where the main concern is minimizing
the mortality from multiple organ dysfunction syn-
drome (MODS) and late (from 2 weeks onwards)
where septic complications, particularly infected pan-
creatic necrosis (IPN) are the primary concern,
whether or not MODS is present. The morbidity
and mortality of the early phase are associated with
disordered systemic homeostasis, and local peri-pan-
creatic complications are rare. Randomized studies of
surgical [5], endoscopic [68] or pharmacological
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intervention [9,10] have unfortunately failed to show
any advantage over optimized supportive therapy, and
this has led to an early management strategy based on
the principles of organ and nutritional support.
Late complications, often peri-pancreatic, may arise
in those patients surviving the initial period of organ
dysfunction, most commonly driven by bacterial (or
fungal) colonization of the pancreatic/peri-pancreatic
collection. It has also been assumed that this required
immediate intervention, as the patient would not
recover until complete debridement had been
achieved. Surgery in patients with established sepsis-
driven organ failure is associated with a poor out-
come, and this led to attempts at early identification
of infection by radiologically guided fine-needle
aspiration (FNA) [11], with a view to almost prophy-
lactic surgical intervention before secondary organ
compromise developed. However, it is evident that
not all patients with infected necrosis are unwell, and
consequently the universal requirement for interven-
tion is overstated. In most surgical conditions, sepsis-
driven organ failure results from inadequate drainage
of the septic focus, rather than its contents. Within the
Glasgow Unit, our approach has therefore evolved to
one of sepsis control rather than a preoccupation with
either necrosis or bacterial contamination.
Most specialist centres have addressed pancreatic
sepsis by way of a single treatment approach, despite
the diversity of presentation and clinical condition of
the patient. We look on the diversity of described
techniques as complementary rather than exclusive. A
variety of approaches may be appropriate depending
on the anatomical location of the collection, the
duration from presentation and the clinical well-being
of the patient at that particular time.
Our approach is to avoid intervention unless we
suspect that the patient’s clinical condition is being
compromised by an undrained, presumably infected,
collection. The initiator for sequential imaging,
usually by way of CT, is therefore a secondary
deterioration in organ failure scores or serial biochem-
istry, rather than routine interval CT scanning or a
protocol-driven repetitive FNA approach. In those
patients in whom clinical sepsis is suspected, contrast-
enhanced CT is performed with a view to probable
intervention, the nature of which is determined by
the clinical condition of the patient and the time
course from initial presentation.
As a general principle, the mortality associated with
secondary infection of a pancreatic collection lessens
as the collection matures, being in excess of 25%
for true pancreatic necrosis and almost zero for a
pancreatic abscess. Mortality is also associated with
collections with a high ratio of solid components, and
careful radiological assessment is essential before
treatment. The aim is therefore to avoid intervention
whilst any necrosis-associated collection is in the
maturation phase; however, intervention may become
necessary owing to clinical deterioration. When early
intervention is required we try to minimize the surgical
insult even if this means a requirement for interval
procedures once sepsis is controlled, rather than adopt
the traditional open necrosectomy approach.
Key to this policy is an understanding of the
evolving pathology of post acute, necrosis-associated
collections in pancreatitis. The aim of intervention is
the ‘adequate and maintained control of sepsis’. The
success of various approaches is dependent on the
anatomical position and particularly the ratio of solid
to fluid components within the collection. The devel-
opment of secondary infection may be the likely
initiator that demands intervention, but the timescale
and patho-radiological appearance will influence the
optimum intervention. The process of maturation or
‘organization’, with separation and partial liquefaction
of the solid components within a collection, takes in
excess of 12 weeks to complete, during which four
stages can be recognized. (1) True pancreatic necrosis
 minimal separation of devitalized tissue with a high
solid/fluid ratio. (2) Transitional pancreatic necrosis.
(3) Organized pancreatic necrosis (OPN)  good
separation of devitalized tissue within a fluid-filled
cavity, and formation of a fibrous wall lined with
granulation tissue. (4) Pseudocyst  almost complete
resolution of any solid component and a well formed
fibrous wall lined with granulation tissue.
Management of infected pancreatic collections
True pancreatic necrosis
The late peak in the mortality curve associated with
acute pancreatitis results from secondary infection of
the devitalized tissue and sepsis-driven secondary
organ dysfunction. This peak occurs early in the
recovery phase (24 weeks), when organization of
the peri-pancreatic collection is incomplete, and
radiological targets are poorly defined. Aggressive
open surgical exploration encounters semi-adherent
devitalized tissue, which results in bleeding if re-
moved. Staged open approaches of open laparostomy,
closed packing or closed lavage are all attempts at
controlling sepsis in the presence of incomplete
debridement. For some time we have argued that
complete debridement is in any case unnecessary, and
provided that adequate control of sepsis is main-
tained, organ failure will recover and removal of
necrosis may be achieved in a delayed fashion.
Mortality is highest in patients with established
organ dysfunction requiring intervention during the
early ‘true necrosis’ phase. Following open surgical
debridement, despite maximal supportive measures,
terminal postoperative decline is not uncommon.
In these patients, a staged approach with initial
radiological drainage to downstage the septic process
will often result in a short period during which
organ dysfunction may improve. Delaying definitive
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intervention/drainage to coincide with this therapeu-
tic window may be appropriate.
It is in these patients that we most commonly utilize
the percutaneous necrosectomy approach [12], the
aim of the procedure being to control sepsis rather
than achieve debridement. In this, within 24
36 hours of initial CT-guided puncture and drainage,
the patient undergoes tract dilatation, cavity irrigation
and partial debridement. Under general anaesthesia
the patient is placed supine with sand-bags used to
optimize access to the drain site, which is ideally
utilizing a left flank approach via the lieno-colic
window, to promote dependent drainage. A guidewire
is used to exchange the drain for a 30FG balloon
dilator (Cook Ltd, Herts, UK) followed by a grad-
uated dilator to 34FG to allow insertion of an
Amplatz sheath. Cavity lavage (normal saline at
body temperature is infused via a rapid infuser) and
suction using a modified nephrostomy rigid rod lens
system until the fluid within the cavity allows ade-
quate visualization. At the initial procedure the aim is
to achieve adequate and sustainable sepsis control,
rather than debridement, and so while piecemeal
removal of any loose necrotic material is performed,
prolonged attempts at debridement during the initial
procedure are avoided as this may result in worsening
sepsis and systemic compromise. An 8 Fr umbilical
catheter is sutured to a 32 Fr Portex chest drain
(SIMS Portex Ltd, Kent, UK) in two positions and
this is advanced into the cavity. Closed lavage at
250 ml/h is commenced and continued postopera-
tively. A median of three, secondary interval proce-
dures are usually required over the coming weeks,
hopefully in a patient with improving organ dysfunc-
tion and controlled sepsis.
Organized pancreatic necrosis (OPN)
These patients are in general in reasonable health,
having been nursed through the initial 1012 weeks of
the illness. Pressure symptoms, pain, non-resolution
of a large collection/abdominal mass or occasionally
infection are the common indications for intervention.
Previous reports recommending intervention for non-
resolving collections before this time have little clinical
basis. Significant organ dysfunction or sepsis are rare
and our approach is toward managing the collection
as a single intervention. Our preference is for a trans-
gastric necrosectomy, allowing adequate surgical
drainage and removal of any separated necrotic
material at the same time. This procedure may be
performed either by open surgery or by a laparo-
scopic, intra-visceral approach (although this proce-
dure is still within an evaluation phase and would
not be considered standard management). Both have
the advantage that a simultaneous cholecystectomy
(with cholangiogram) can be performed. The open
approach has been described extensively before. The
laparoscopic approach involves insertion of a sub-
umbilical blunt port using a cut-down technique.
Intra-abdominal inflammatory adhesions are not
uncommon and a Veress needle approach is not
recommended. An endoscope is passed perorally,
and 100 ml of saline is instilled into the duodenum
to act as a sump. The stomach is inflated using the
endoscope and utilizing dual imaging (endogastric
and intraperitoneal), three ‘Step ports’ (Tyco Health-
care Ltd, Hampshire, UK) (2/12 mm and 1/
5 mm) are then inserted through the abdominal wall
and into the stomach. These are then dilated to allow
intragastric insertion of the laparoscope. The OPN
collection is identified on laparoscopic ultrasound,
allowing diathermy-assisted puncture of the cavity. A
cystgastrostomy (1012 cm in length) is then created
using three firings of the Endo GIA stapler. Any
necrosis can be removed and placed in the fundus.
The ports are removed and the gastrotomy puncture
sites are closed by intracorporeal suture.
In some patients, large OPN collections require
drainage but the patients are either frail, morbidly
obese or significant co-morbidity makes an operative
approach unattractive. In these patients we utilize an
aggressive EUS-guided cystgastrostomy approach
[13]. EUS-guided cystgastrostomy is modified to
allow dilatation of the cystgastrostomy tract using a
15 mm balloon at the time of initial puncture. Two
double pigtail stents maintain tract patency in addi-
tion to cavity lavage using a naso-cystic catheter,
irrigating the cavity using warmed dialysis fluid at
100 ml/h. Secondary endoscopic procedures to allow
tract dilatation (20 ml balloon), occasionally com-
bined with intracavity endoscopy and piecemeal
debridement, are usually required prior to resolution.
Transitional pancreatic necrosis
Patients falling between the two extremes described
above often present the greatest management chal-
lenge. Timing and choice of intervention can be
difficult and the wrong choice has the potential to
worsen the clinical situation. Between 3 and 10 weeks
after illness onset, patients with infected pancreatic
necrosis may be managed by a variety of approaches.
As a general principle we would prefer to delay
intervention to allow organization to occur, and we
would consider giving antibiotics if the patient’s
clinical condition allowed. We have occasionally ob-
served complete resolution in some patients with
antibiotic therapy alone but in most cases some
form of definitive drainage is necessary.
In those patients who have ongoing sepsis and
MOF, our approach is similar to that in patients
with early IPN, with percutaneous drainage and
necrosectomy. Patients with no organ dysfunction
but demonstrable infected necrosis may be managed
by laparoscopic transgastric drainage if sufficiently
late in the course of the illness, but this technique is
less suitable for patients B/810 weeks from onset.
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Patients showing signs of clinical deterioration while
on antibiotic therapy will undergo percutaneous
necrosectomy if B/8 weeks from illness onset.
A percutaneous necrosectomy approach will result
in a prolonged hospital stay, and inevitably serial
interventions compared with a single transgastric
intervention. Our general aim is therefore to manage
these patients by conservative means if possible to
allow maturation to occur. If demanded by the
presence of sepsis or symptoms, the type of interven-
tion will be governed by the degree of associated
organ failure and the suitability for a trans-gastric
approach, our preference being for intervention along
a one-stop OPN algorithm, reserving a percutaneous
approach for those with significant co-morbidity or
organ dysfunction in whom a single intervention may
be considered excessive.
Pseudocyst
By definition a pseudocyst contains minimal necrosis,
and its management  and that of pancreatic abscess
(infected pseudocyst with minimal necrosis)  in
patients following an attack of acute pancreatitis, is
usually by trans-gastric drainage. Following acute
pancreatitis, many patients with apparent ‘pseudo-
cysts’ will have significant necrosis which may not be
obvious on CT but which is easily identified on MRI
or at EUS. Transpapillary drainage, as favoured for
simple pseudocysts, runs the risk of infecting these
necrotic collections and we therefore favour transgas-
tric drainage under EUS guidance. Where there is
minimal necrosis and no infection, two pigtail stents
are left in place without the use of a naso-cyst lavage
catheter but where there is significant necrosis, these
patients are managed as with OPN by post-procedural
lavage. Follow-up trans-abdominal ultrasound is car-
ried out within 48 h to ensure that the cyst has been
adequately drained, and if not, further endoscopic
dilatation of the cystgastrostomy track is carried out.
Rarely, patients may have persistent pseudocysts
despite endoscopic drainage and this is usually due to
disconnected duct syndrome. This occurs when
central pancreatic necrosis results in complete dis-
connection of the pancreatic tail, which remains
functional. These patients usually need distal pan-
createctomy, although in patients with comorbidity
prolonged relief can be obtained by EUS-guided
drainage, leaving the stents in situ for an indefinite
period.
Secondary haemorrhage and enteric fistulation are
the two most common surgical complications within
the recovery phase. Bleeding into the retroperitoneum
is evident from the presence of fresh blood in a lavage
catheter. Gastrointestinal bleeding may also be seen
but is usually associated with a retroperitoneal source
and fistulation into the GI tract. In either situation,
the preferred management is mesenteric angiography
and embolization. The usual bleeding site is the
splenic artery or, less commonly, the gastroduodenal
artery, but other sites may be involved, particularly
where there is extensive necrosis of the pancreatic
head. A small ‘herald’ bleed is common and ward staff
must be alert to this complication so that urgent
arrangements for angiography are made before the
inevitable massive bleeding ensues. Failure of mesen-
teric embolization obviously necessitates surgical
intervention, but in these cases prognosis is very poor.
Gastrointestinal fistulae are commonly seen in the
later stages of management of infected pancreatic
necrosis. Most cases are due to focal colonic necrosis,
and are managed by simple defunctioning ileostomy,
which we perform through a small trephine incision.
More extensive colonic necrosis presents as cata-
strophic worsening of MOF but in our experience
is very rare unless open necrosectomy has been
carried out.
Duodenal and gastric fistulae can be managed
conservatively, although a period of TPN may be
required. Pancreatic fistulae are expected following
percutaneous necrosectomy. Patients may be sent
home with a soft catheter in place and this can be
removed at the outpatient clinic when drainage
stops, usually within 34 weeks. Persistent fistulae
may necessitate pancreatic duct stenting or rarely
distal pancreatectomy in cases of disconnected duct
syndrome.
Conclusion
Management strategies for patients presenting with
acute pancreatitis associated with significant pancrea-
tic and peri-pancreatic necrosis have changed radi-
cally in the last 10 years. Previously held dogma and
uncompromising surgical strategies have matured into
a complex and dynamic multi-modal management
strategy. Central to this is the timing of intervention
and a flexibility of approach. Clinical organ dysfunc-
tion is now recognized as being more significant in
terms of outcome than either the presence of necrosis
or infection. Inadequate drainage of sepsis is the key
to that organ failure and therefore ultimately mortal-
ity. However, general principles remain: to avoid any
major procedure in a patient with organ dysfunction
and where possible to delay intervention, allowing
organization of the necrosis, until a phase when
morbidity and mortality are minimal.
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